Tradestie Institutional Equity Comparison Engine
GMGI vs ABUS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABUS Overall Edge
ABUS Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arbutus Biopharma Corporation Common Stock (ABUS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GMGI trades at 128.2x Forward P/E with -0.8% operating margin (+15.4% YoY revenue) versus ABUS at 10.2x Forward P/E and 80.1% operating margin (-43.5% YoY). In options structure, GMGI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABUS sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ABUS
GMGI 128.2x vs ABUS 10.2x Fwd P/E
Growth & Margin Winner
ABUS
Op Margin -0.8% vs 80.1% ยท YoY +15.4% vs -43.5%
Momentum & Technical Winner
ABUS
1Y -67.7% vs -5.8% ยท 52W Pos 9% vs 27%
Options & Structure Winner
ABUS
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (18th %ile IV)
GMGI
NASDAQ
Golden Matrix Group, Inc. Common Stock
Services-Prepackaged Software
$0.64
+9.86% 1D
Market Cap
$81.9M
1M Return
-7.45%
1Y Return
-67.65%
Forward P/E
128.2x
Unified AI Score
51.1 / 100
HOLD
Tech 60.0
Fund 45.0
Flow 50.0
Mom 38.2
ABUS
NASDAQ
Arbutus Biopharma Corporation Common Stock
Pharmaceutical Preparations
$4.02
-1.23% 1D
Market Cap
$623.9M
1M Return
-4.51%
1Y Return
-5.85%
Forward P/E
10.2x
Unified AI Score
43.4 / 100
HOLD
Tech 28.0
Fund 48.0
Flow 68.0
Mom 53.7
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GMGI -67.65%
ABUS -5.85%
Spread: +33.79 pp (ABUS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GMGI TTM Op. Margin: -0.8%
ABUS TTM Op. Margin: 80.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GMGI vs ABUS. Trailing 12-month operating profitability (GMGI -0.8% vs ABUS 80.1%) and valuation multiples (GMGI 128.2x vs ABUS 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GMGI | ABUS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $81.9M | $623.9M | Larger Scale | ABUS |
| Trailing P/E Ratio Valuation | 128.2x | 3.6x | Lower Multiple | ABUS |
| Forward P/E Ratio Valuation | 128.2x | 10.2x | Lower Multiple | ABUS |
| Revenue Growth (YoY) Growth | +15.4% | -43.5% | Higher Growth | GMGI |
| Operating Margin (TTM) Profitability | -0.8% | 80.1% | Higher Margin | ABUS |
| Net Profit Margin Profitability | -3.0% | 121.2% | Higher Margin | ABUS |
| Return on Equity (ROE) Capital Efficiency | -5.0% | 269.6% | Higher ROE | ABUS |
| 52-Week Range Position Momentum | 9% ($0โ$2) | 27% ($4โ$5) | Stronger Trend | ABUS |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 117% Vol | 1.04ฮฒ ยท 48% Vol | Lower Realized Risk | ABUS |
| Unified Institutional Score Composite Signal | 51.1 / 100 (HOLD) | 43.4 / 100 (HOLD) | Higher Composite | GMGI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GMGI vs ABUS Buy Guide
GMGI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ABUS
CONSOLIDATION
96d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
18th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GMGI nor ABUS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.